About Company
Our Story
Mission
Vision
Our Story
About Us
Angsana Molecular & Diagnostic Laboratory (AMDL) Pte Ltd was established in 2014, and specializes in developing panelised genetic, genomic and molecular-based tests. Our laboratory developed assays in three specialities:
- Allergy and Molecular Allergology,
- Fetal and Maternal Health and
- Molecular Oncology
AMDL is a licensed laboratory by the Ministry of Health Singapore and is also accredited by the College of American Pathologists (CAP) since 2015. With this, we can assure our clinicians and patients that our tests are robust and meet high standards of clinical quality. AMDL also has strategic tie-ups with several internationally branded healthcare companies to offer a full complement of 21st century healthcare tools to our valued clinical partners in Singapore and beyond.
Mission
As a diverse team of committed experts dedicated to supporting and enhancing the healthcare of Asian individuals and communities, we aim to enhance their quality of life and promote informed decision-making.
Through premium services, personalized medical insights, comprehensive public education initiatives, and continuous innovation, we empower both doctors and patients to make smarter healthcare choices.Vision
Angsana Molecular and Diagnostics aims to be a healthcare company committed to advancing cutting edge medical care.
Why choose us
Quality Assurance
With CAP accreditation for laboratory facilities, we will ensure the highest standards of service.
Actionable Insights
Experience precision healthcare through actionable insights in oncology, allergy testing, and fetomaternal health, tailored to your unique needs.
Affordable and Fast Turnaround Time
Our diverse team delivers cost-effective services and the swift delivery of crucial genetic insights without compromising quality.
Premium Services
Discover our premium services, blending cutting-edge genomic technologies with validated assays for unmatched accuracy and speed.
Our Partners
Our Team - Management
Our Partners
THERMOFISHER SCIENTIFIC
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue over $40 billion. Their Mission is to enable their customers to make the world healthier, cleaner and safer. Whether their customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, they are here to support them. Their global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
BIOCARTIS
Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions, aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus in oncology which represents the fastest growing segment of the MDx market worldwide. Today, Biocartis offers tests supporting melanoma, colorectal and lung cancer, as well as for sepsis.
Biocartis’ proprietary molecular diagnostics (MDx) IdyllaTM platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from virtually any biological sample, in virtually any setting, allowing fast and effective treatment selection and treatment progress monitoring.
Biocartis is headquartered in Mechelen, Belgium.
MYRIAD GENETICS
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual’s risk for developing disease later in life (predictive medicine), identify a patient’s likelihood of responding to a particular drug therapy (precision medicine), assess a patient’s risk of disease progression and disease recurrence (precision medicine), and measure disease activity.
IGENE LABORATORY
Established in 2014, iGene Laboratory is a wholly owned subsidiary of INEX Innovate. Located in Singapore, iGene Laboratory serves medical professionals and patients’ region-wide across the South East Asian and beyond by offering tests based on technology platforms such as Next Generation Sequencing (NGS) and, Polymerase Chain Reaction (PCR). iGene Laboratory is licensed by the Singapore Ministry of Health (MOH) and accredited by the College of American Pathologists (CAP) in Next Generation Sequencing (NGS) and Molecular Microbiology including COVID-19 testing services. iGene Laboratory subscribes to GenQA and QCMD standards
NATERA
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives.
